Table 2.
Analysis (ANCOVA) of the primary and secondary outcomes.
| Exercise (n = 29) | TAU (n = 27) | |||||||
|---|---|---|---|---|---|---|---|---|
| Variables | Pre- | Post- | Δ% | Pre- | Post- | Δ% | p | Ƞ2 |
| GH 20’ (ng/mL) | 2.87 (2.88) | 4.74 (6.00) | 65.2 | 3.76 (4.84) | 3.38 (5.21) | −10.1 | 0.048 | 0.07 |
| GH (ng/mL) | 3.65 (3.89) | 3.45 (4.57) | −5.5 | 2.40 (2.72) | 2.60 (4.99) | 8.3 | 0.656 | <0.01 |
| VO2 Max. (ml/kg/min) a | 20.06 (5.58) | 22.02 (5.68) | 9.8 | 19.18 (4.60) | 18.47 (4.17) | −3.7 | 0.006 | 0.15 |
| Pressure (cm3) b | 5.68 (2.58) | 6.53 (2.68) | 15.0 | 5.58 (2.70) | 5.94 (2.17) | 6.5 | 0.296 | 0.02 |
| BMI (kg/m2) | 26.71 (3.90) | 26.64 (4.15) | −0.3 | 27.03 (5.89) | 26.43 (5.66) | −2.2 | 0.091 | 0.05 |
| Σ skinfolds | 156.78 (43.77) | 141.23 (39.39) | −9.9 | 153.41 (51.65) | 149.37 (42.72) | −2.6 | 0.042 | 0.08 |
| FIQ | 66.90 (14.44) | 58.71 (19.08) | −12.4 | 75.81 (14.08) | 68.36 (20.44) | −9.8 | 0.807 | <0.01 |
| EQ-5D | 0.22 (0.29) | 0.40 (0.34) | 81.8 | 0.21 (0.31) | 0.23 (0.31) | 8.7 | 0.019 | 0.10 |
Note. Scores in pre- and post- are means (SDs). Δ% = increase percentage. a Five participants could not finish the Max.VO2 test in the TAU group. b Three participants did not accomplish the pressure test in the TAU group.